Skip to Main content Skip to Navigation
Journal articles

Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial

Abstract : Background: This study describes the effect of TG4010 vaccine on Health related Quality of Life (HRQOL) in patients with stage IIIb and IV non-small-cell lung cancer (NSCLC). Methods: 148 patients with advanced NSCLC expressing MUC1 were randomly assigned to receive TG4010 plus chemotherapy or chemotherapy alone. HRQOL was assessed with the Functional Assessment of Cancer Therapy-Lung (FACT-L) at baseline and every 6 weeks until disease progression. Time until definitive deterioration (TUDD) of the four well-being dimensions of the FACT-L physical (PWB), functional (FWB), emotional (EWB) and social well-being (SWB) and the Lung Cancer Subscale (LCS) domains were analyzed for a 5-point minimal clinically important difference. Results: No difference of TUDD of HRQOL has been found between treatment arms. No prognostic factors have been found to have a significant impact on the TUDD of PWB, SWB and LCS domains. The gender, the performance status and the smoking habits seemed to be associated with a shorter TUDD of EWB domain. The smokers and the former smokers seemed to present a shorter TUDD of FWB domain. Conclusion: This study suggests that adding therapeutic vaccination with TG4010 to standard chemotherapy in patients with advanced NSCLC is associated with a similar evolution in HRQOL compared to chemotherapy alone.
Document type :
Journal articles
Complete list of metadatas

https://hal.univ-lorraine.fr/hal-02944879
Contributor : Christine Rotonda <>
Submitted on : Monday, September 21, 2020 - 5:36:03 PM
Last modification on : Tuesday, October 27, 2020 - 2:34:47 PM

Links full text

Identifiers

Collections

Citation

Christine Rotonda, Amelie Anota, Mariette Mercier, Bérangère Bastien, Gisèle Lacoste, et al.. Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial. PLoS ONE, Public Library of Science, 2015, 10 (7), pp.e0132568. ⟨10.1371/journal.pone.0132568⟩. ⟨hal-02944879⟩

Share

Metrics

Record views

26